PNC Financial Services Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38K | Hold |
1,461
| – | – | ﹤0.01% | 4505 |
|
|
2025
Q1 | $673 | Buy |
1,461
+1,350
| +1,216% | +$622 | ﹤0.01% | 4579 |
|
|
2024
Q4 | $82 | Hold |
111
| – | – | ﹤0.01% | 4717 |
|
|
2024
Q3 | $174 | Hold |
111
| – | – | ﹤0.01% | 4692 |
|
|
2024
Q2 | $186 | Hold |
111
| – | – | ﹤0.01% | 4676 |
|
|
2024
Q1 | $266 | Hold |
111
| – | – | ﹤0.01% | 4577 |
|
|
2023
Q4 | $170 | Buy |
+111
| New | +$170 | ﹤0.01% | 4497 |
|
|
2019
Q4 | – | Sell |
-34
| Closed | – | – | 4054 |
|
|
2019
Q3 | $0 | Hold |
34
| – | – | ﹤0.01% | 4064 |
|
|
2019
Q2 | $0 | Hold |
34
| – | – | ﹤0.01% | 4085 |
|
|
2019
Q1 | $0 | Hold |
34
| – | – | ﹤0.01% | 4086 |
|
|
2018
Q4 | $0 | Sell |
34
-4,428
| -99% | – | ﹤0.01% | 4117 |
|
|
2018
Q3 | $48K | Buy |
4,462
+340
| +8% | +$3.66K | ﹤0.01% | 3021 |
|
|
2018
Q2 | $49K | Buy |
4,122
+4,067
| +7,395% | +$48.3K | ﹤0.01% | 2987 |
|
|
2018
Q1 | $0 | Sell |
55
-13
| -19% | – | ﹤0.01% | 4239 |
|
|
2017
Q4 | $0 | Buy |
68
+29
| +74% | – | ﹤0.01% | 4201 |
|
|
2017
Q3 | $0 | Sell |
39
-136
| -78% | – | ﹤0.01% | 4191 |
|
|
2017
Q2 | $3K | Buy |
+175
| New | +$3K | ﹤0.01% | 3926 |
|
|
2016
Q3 | – | Sell |
-243
| Closed | -$3K | – | 4144 |
|
|
2016
Q2 | $3K | Sell |
243
-9
| -4% | -$111 | ﹤0.01% | 4039 |
|
|
2016
Q1 | $3K | Buy |
252
+9
| +4% | +$107 | ﹤0.01% | 4049 |
|
|
2015
Q4 | $3K | Hold |
243
| – | – | ﹤0.01% | 4044 |
|
|
2015
Q3 | $3K | Buy |
243
+8
| +3% | +$99 | ﹤0.01% | 4153 |
|
|
2015
Q2 | $2K | Sell |
235
-665
| -74% | -$5.66K | ﹤0.01% | 4405 |
|
|
2015
Q1 | $1K | Hold |
900
| – | – | ﹤0.01% | 4492 |
|
|
2014
Q4 | $1K | Hold |
900
| – | – | ﹤0.01% | 3996 |
|
|
2014
Q3 | $1K | Hold |
900
| – | – | ﹤0.01% | 3839 |
|
|
2014
Q2 | $1K | Hold |
900
| – | – | ﹤0.01% | 3691 |
|
|
2014
Q1 | $2K | Buy |
+900
| New | +$2K | ﹤0.01% | 3488 |
|